Observational Study
Copyright ©2014 Baishideng Publishing Group Inc.
World J Hematol. Aug 6, 2014; 3(3): 105-114
Published online Aug 6, 2014. doi: 10.5315/wjh.v3.i3.105
Table 3 Detailed information regarding karyotype categories according to the National Comprehensive Cancer Network, Southwest Oncology Group, and Cancer and Leukemia Group B classifications
CategoryFavorableIntermediateUnfavorableCategory not recognized
NCCNt(8;21)+8, t(9;11), -X, -Y, -6, +1, +4, +7, +11, +13, +21, del(9), del(20), add(12), add(16), add(17), inv(3), t(1;16), t(3;21), t(8;18), t(8;20), t(11;16), t(11;17)–5, del(5q), -7, non-t(9;11) abn11q23, inv(3), t(9;22), complex karyotype ≥ 3-
SWOGt(8;21)-Y, +8abn(3q), -5, -7, t(9;22), abn(9q), abn(11q), abn(17p), abn(20q), abn(21q), complex karyotype ≥ 3t(9;11), -X, -6, +1, +4, +7, +11, +13, +21, add(12), add(16), inv(3), t(1;16), t(3;21), t(8;18), t(8;20)
CALGBt(8;21), del(9q)-Y, del(5q), t(9;11), +11, del(11q), abn(12p), +13, del(20q), +21inv(3), -7, +8, complex karyotype ≥ 3-X, -6, +1, +4, +7, add(12), add(16), add(17), t(1;16), t(3;21), t(8;18), t(8;20), t(11;16), t(11;17)